BIOX icon

Bioceres Crop Solutions

1.91 USD
-0.04
2.05%
At close Updated Sep 16, 3:59 PM EDT
1 day
-2.05%
5 days
-15.11%
1 month
-36.33%
3 months
-60.46%
6 months
-58.75%
Year to date
-71.58%
1 year
-77.79%
5 years
-66.49%
10 years
-80.1%
 

About: Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Employees: 983

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

3% more funds holding

Funds holding: 37 [Q1] → 38 (+1) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

0.27% less ownership

Funds ownership: 21.78% [Q1] → 21.51% (-0.27%) [Q2]

3% less capital invested

Capital invested by funds: $62.3M [Q1] → $60.3M (-$2.04M) [Q2]

36% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 11

50% less call options, than puts

Call options by funds: $39K | Put options by funds: $78K

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$2.5
31% upside
Avg. target
$4.5
136% upside
High target
$6
214% upside

3 analyst ratings

positive
67%
neutral
33%
negative
0%
Lake Street
Ben Klieve
$5
Buy
Maintained
10 Sep 2025
Canaccord Genuity
Austin Moeller
$2.5
Hold
Downgraded
10 Sep 2025
Oppenheimer
Kristen Owen
$6
Outperform
Maintained
15 Jul 2025

Financial journalist opinion

Based on 6 articles about BIOX published over the past 30 days

Negative
Seeking Alpha
6 days ago
Bioceres At Its Worst Juncture, Equity Dilution Seems Very Possible
Bioceres reported a disastrous year with sales down 30%, margins collapsing, and large unexplained debt losses, resulting in a $60 million net loss. The company faces severe liquidity and capital allocation risks, with high-interest debt, unclear disclosures, and increased dilution risk from convertible notes. Management and board instability, along with poor reporting transparency, further undermine confidence in Bioceres' ability to navigate its challenges.
Bioceres At Its Worst Juncture, Equity Dilution Seems Very Possible
Negative
Seeking Alpha
6 days ago
Bioceres Crop Solutions: Waiting For Gross Profit To Turn (Downgrade)
Downgrade Bioceres Crop Solutions Corp. to Hold due to Argentina's volatile currency, credit constraints, and a challenging shift in the seed sales model. Recent results show sharply lower revenues, deeper losses, but disciplined cash management, and a focus on cost reductions going forward. Valuation sits at 3.5x gross profit and 8.5–11x EV/EBITDA, but earnings risk and potential dilution remain high.
Bioceres Crop Solutions: Waiting For Gross Profit To Turn (Downgrade)
Neutral
Seeking Alpha
7 days ago
Bioceres Crop Solutions Corp. (BIOX) Q4 2025 Earnings Call Transcript
Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q4 2025 Earnings Call September 9, 2025 8:30 AM EDT Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Executive Chairman & CEO Conference Call Participants Kristen Owen - Oppenheimer & Co. Inc., Research Division Benjamin Klieve - Lake Street Capital Markets, LLC, Research Division Austin Moeller - Canaccord Genuity Corp., Research Division Brian Kemp Dolliver - Brookline Capital Markets, LLC, Research Division Presentation Operator Welcome all to the Bioceres Crop Solutions Fiscal Fourth Quarter and Full Year 2025 Financial Results. My name is Drew, and I'll be the operator on the call today.
Bioceres Crop Solutions Corp. (BIOX) Q4 2025 Earnings Call Transcript
Neutral
Business Wire
7 days ago
Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2025 Financial and Operational Results
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter ended June 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in t.
Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2025 Financial and Operational Results
Neutral
Business Wire
13 days ago
Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2025 Financial Results Conference Call on Tuesday, September 9, 2025 at 8:30 a.m. Eastern Time
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, September 9, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal fourth quarter and full year ended June 30, 2025. A press release detailing these result.
Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2025 Financial Results Conference Call on Tuesday, September 9, 2025 at 8:30 a.m. Eastern Time
Positive
Benzinga
18 days ago
Top 3 Materials Stocks That Are Set To Fly This Month
The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
Top 3 Materials Stocks That Are Set To Fly This Month
Neutral
Business Wire
2 months ago
Bioceres Crop Solutions Announces Changes to Board of Directors
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, today announced changes to the composition of its Board of Directors. Noah Kolatch and Scott Crocco are being appointed to the Company's Board of Directors with effect from June 24, 2025. Noah Kolatch is a Principal at Jaspe.
Bioceres Crop Solutions Announces Changes to Board of Directors
Neutral
Seeking Alpha
3 months ago
Bioceres Q3 2025 Illustrates The Financial Challenges And A Distressed Argentinian Market
Bioceres faces mounting financial stress, with Argentina's weak agriculture sector and loss of Syngenta payments driving revenue and EBITDA declines. Cash flow is tightening rapidly; asset sales and one-off inventory benefits are masking underlying losses, while debt and interest costs loom large. Long-term product developments like HB4 and RINO offer potential, but have yet to deliver meaningful, scalable revenue or margin improvements.
Bioceres Q3 2025 Illustrates The Financial Challenges And A Distressed Argentinian Market
Neutral
Seeking Alpha
3 months ago
Bioceres Crop Solutions Corp. (BIOX) Q3 2025 Earnings Call Transcript
Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q3 2025 Results Conference Call May 21, 2025 8:30 AM ET Company Participants Paula Savanti - Head, Investor Relations Federico Trucco - Chief Executive Officer Enrique López Lecube - Chief Financial Officer Milen Marinov - Chief Commercial Officer Conference Call Participants Kristen Owen - Oppenheimer Ben Klieve - Lake Street Capital Markets Austin Moeller - Canaccord Steve Byrne - Bank of America Kemp Dolliver - Brookline Capital Markets Operator Hello, everyone, and thank you for joining us on today's Bioceres Crop Solutions Fiscal Third Quarter 2025 Financial and Operational Results. My name is Drew and I'll be the operator on today's call.
Bioceres Crop Solutions Corp. (BIOX) Q3 2025 Earnings Call Transcript
Negative
Zacks Investment Research
3 months ago
Bioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates
Bioceres Crop (BIOX) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to earnings of $0.14 per share a year ago.
Bioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates
Charts implemented using Lightweight Charts™